Pyoderma gangrenosum (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pyoderma gangrenosum" in English language version.

refsWebsite

Global rank English rank

21nih.gov

4^th place

16doi.org

2^nd place

6semanticscholar.org

11^th place

8^th place

1emedicine.com

3,595^th place

3,333^rd place

1jamanetwork.com

2,650^th place

3,409^th place

1handle.net

102^nd place

76^th place

doi.org

Partridge AC, Bai JW, Rosen CF, Walsh SR, Gulliver WP, Fleming P (August 2018). "Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials". The British Journal of Dermatology. 179 (2): 290–295. doi:10.1111/bjd.16485. PMID 29478243. S2CID 3504429.
Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G (September 2009). "Pyoderma gangrenosum: an updated review". Journal of the European Academy of Dermatology and Venereology. 23 (9): 1008–17. doi:10.1111/j.1468-3083.2009.03199.x. PMID 19470075. S2CID 29773727.
Brooklyn T, Dunnill G, Probert C (July 2006). "Diagnosis and treatment of pyoderma gangrenosum". BMJ. 333 (7560): 181–4. doi:10.1136/bmj.333.7560.181. PMC 1513476. PMID 16858047.
Shankar S, Sterling JC, Rytina E (November 2003). "Pustular pyoderma gangrenosum". Clinical and Experimental Dermatology. 28 (6): 600–3. doi:10.1046/j.1365-2230.2003.01418.x. PMID 14616824. S2CID 11350602.
Langan SM, Powell FC (August 2005). "Vegetative pyoderma gangrenosum: a report of two new cases and a review of the literature". International Journal of Dermatology. 44 (8): 623–9. doi:10.1111/j.1365-4632.2005.02591.x. PMID 16101860. S2CID 34574262.
Brooklyn T, Dunnill G, Probert C (July 2006). "Diagnosis and treatment of pyoderma gangrenosum". BMJ. 333 (7560): 181–4. doi:10.1136/bmj.333.7560.181. PMC 1513476. PMID 16858047.
Tendas A, Niscola P, Barbati R, Abruzzese E, Cuppelli L, Giovannini M, et al. (May 2011). "Tattoo related pyoderma/ectyma gangrenous as presenting feature of relapsed acute myeloid leukaemia: an exceptionally rare observation". Injury. 42 (5): 546–7. doi:10.1016/j.injury.2010.08.014. PMID 20883993.
Genovese G, Moltasio C, Garcovich S, Marzano AV (2020). "PAPA Spectrum Disorders". Italian Journal of Dermatology and Venereology. 155 (5): 542–550. doi:10.23736/S0392-0488.20.06629-8. PMID 32618443.
Smith EJ, Allantaz F, Bennett L, Zhang D, Gao X, Wood G, Kastner DL, Punaro M, Aksentijevich I, Pascual V, Wise CA (2010). "Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review". Current Genomics. 11 (7): 519–527. doi:10.2174/138920210793175921. PMC 3048314. PMID 21532836.
Patel F, Fitzmaurice S, Duong C, He Y, Fergus J, Raychaudhuri SP, et al. (May 2015). "Effective strategies for the management of pyoderma gangrenosum: a comprehensive review". Acta Dermato-Venereologica. 95 (5): 525–31. doi:10.2340/00015555-2008. PMID 25387526.
Claveau JS, Wetter DA, Kumar S (2022). "Cutaneous manifestations of monoclonal gammopathy". Blood Cancer Journal. 12 (4). doi:10.1038/s41408-022-00661-1. PMC 9001632. PMID 35411042. 58.
Marzano AV, Damiani G, Ceccherini I, Berti E, Gattorno M, Cugno M (2017). "Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis)". British Journal of Dermatology. 176 (6): 1588–1598. doi:10.1111/bjd.15226. PMID 27943240.
Rashid RM (November 2008). "Seat belt pyoderma gangrenosum: minor pressure as a causative factor". Journal of the European Academy of Dermatology and Venereology. 22 (10): 1273–4. doi:10.1111/j.1468-3083.2008.02626.x. PMID 18837131. S2CID 27476857.
Weenig RH, Davis MD, Dahl PR, Su WP (October 2002). "Skin ulcers misdiagnosed as pyoderma gangrenosum". The New England Journal of Medicine. 347 (18): 1412–8. doi:10.1056/NEJMoa013383. PMID 12409543.
Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, et al. (April 2018). "Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts". JAMA Dermatology. 154 (4): 461–466. doi:10.1001/jamadermatol.2017.5980. hdl:2434/555642. PMID 29450466. S2CID 4774649.
Reichrath J, Bens G, Bonowitz A, Tilgen W (August 2005). "Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients". Journal of the American Academy of Dermatology. 53 (2): 273–83. doi:10.1016/j.jaad.2004.10.006. PMID 16021123.

emedicine.com

Jackson JM, Callen JP (April 23, 2012). Elston DM (ed.). "Pyoderma Gangrenosum". EMedicine.

handle.net

hdl.handle.net

Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, et al. (April 2018). "Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts". JAMA Dermatology. 154 (4): 461–466. doi:10.1001/jamadermatol.2017.5980. hdl:2434/555642. PMID 29450466. S2CID 4774649.

jamanetwork.com

Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, et al. (April 2018). "Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts". JAMA Dermatology. 154 (4): 461–466. doi:10.1001/jamadermatol.2017.5980. hdl:2434/555642. PMID 29450466. S2CID 4774649.

nih.gov

pubmed.ncbi.nlm.nih.gov

Partridge AC, Bai JW, Rosen CF, Walsh SR, Gulliver WP, Fleming P (August 2018). "Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials". The British Journal of Dermatology. 179 (2): 290–295. doi:10.1111/bjd.16485. PMID 29478243. S2CID 3504429.
Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G (September 2009). "Pyoderma gangrenosum: an updated review". Journal of the European Academy of Dermatology and Venereology. 23 (9): 1008–17. doi:10.1111/j.1468-3083.2009.03199.x. PMID 19470075. S2CID 29773727.
Brooklyn T, Dunnill G, Probert C (July 2006). "Diagnosis and treatment of pyoderma gangrenosum". BMJ. 333 (7560): 181–4. doi:10.1136/bmj.333.7560.181. PMC 1513476. PMID 16858047.
Shankar S, Sterling JC, Rytina E (November 2003). "Pustular pyoderma gangrenosum". Clinical and Experimental Dermatology. 28 (6): 600–3. doi:10.1046/j.1365-2230.2003.01418.x. PMID 14616824. S2CID 11350602.
Langan SM, Powell FC (August 2005). "Vegetative pyoderma gangrenosum: a report of two new cases and a review of the literature". International Journal of Dermatology. 44 (8): 623–9. doi:10.1111/j.1365-4632.2005.02591.x. PMID 16101860. S2CID 34574262.
Brooklyn T, Dunnill G, Probert C (July 2006). "Diagnosis and treatment of pyoderma gangrenosum". BMJ. 333 (7560): 181–4. doi:10.1136/bmj.333.7560.181. PMC 1513476. PMID 16858047.
Schmieder SJ, Krishnamurthy K (4 July 2023). "Pyoderma Gangrenosum". StatPearls. Treasure Island, Florida: StatPearls Publishing. PMID 29489279.
Tendas A, Niscola P, Barbati R, Abruzzese E, Cuppelli L, Giovannini M, et al. (May 2011). "Tattoo related pyoderma/ectyma gangrenous as presenting feature of relapsed acute myeloid leukaemia: an exceptionally rare observation". Injury. 42 (5): 546–7. doi:10.1016/j.injury.2010.08.014. PMID 20883993.
Genovese G, Moltasio C, Garcovich S, Marzano AV (2020). "PAPA Spectrum Disorders". Italian Journal of Dermatology and Venereology. 155 (5): 542–550. doi:10.23736/S0392-0488.20.06629-8. PMID 32618443.
Smith EJ, Allantaz F, Bennett L, Zhang D, Gao X, Wood G, Kastner DL, Punaro M, Aksentijevich I, Pascual V, Wise CA (2010). "Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review". Current Genomics. 11 (7): 519–527. doi:10.2174/138920210793175921. PMC 3048314. PMID 21532836.
Patel F, Fitzmaurice S, Duong C, He Y, Fergus J, Raychaudhuri SP, et al. (May 2015). "Effective strategies for the management of pyoderma gangrenosum: a comprehensive review". Acta Dermato-Venereologica. 95 (5): 525–31. doi:10.2340/00015555-2008. PMID 25387526.
Claveau JS, Wetter DA, Kumar S (2022). "Cutaneous manifestations of monoclonal gammopathy". Blood Cancer Journal. 12 (4). doi:10.1038/s41408-022-00661-1. PMC 9001632. PMID 35411042. 58.
Marzano AV, Damiani G, Ceccherini I, Berti E, Gattorno M, Cugno M (2017). "Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis)". British Journal of Dermatology. 176 (6): 1588–1598. doi:10.1111/bjd.15226. PMID 27943240.
Rashid RM (November 2008). "Seat belt pyoderma gangrenosum: minor pressure as a causative factor". Journal of the European Academy of Dermatology and Venereology. 22 (10): 1273–4. doi:10.1111/j.1468-3083.2008.02626.x. PMID 18837131. S2CID 27476857.
Weenig RH, Davis MD, Dahl PR, Su WP (October 2002). "Skin ulcers misdiagnosed as pyoderma gangrenosum". The New England Journal of Medicine. 347 (18): 1412–8. doi:10.1056/NEJMoa013383. PMID 12409543.
Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, et al. (April 2018). "Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts". JAMA Dermatology. 154 (4): 461–466. doi:10.1001/jamadermatol.2017.5980. hdl:2434/555642. PMID 29450466. S2CID 4774649.
Reichrath J, Bens G, Bonowitz A, Tilgen W (August 2005). "Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients". Journal of the American Academy of Dermatology. 53 (2): 273–83. doi:10.1016/j.jaad.2004.10.006. PMID 16021123.

ncbi.nlm.nih.gov

Brooklyn T, Dunnill G, Probert C (July 2006). "Diagnosis and treatment of pyoderma gangrenosum". BMJ. 333 (7560): 181–4. doi:10.1136/bmj.333.7560.181. PMC 1513476. PMID 16858047.
Brooklyn T, Dunnill G, Probert C (July 2006). "Diagnosis and treatment of pyoderma gangrenosum". BMJ. 333 (7560): 181–4. doi:10.1136/bmj.333.7560.181. PMC 1513476. PMID 16858047.
Smith EJ, Allantaz F, Bennett L, Zhang D, Gao X, Wood G, Kastner DL, Punaro M, Aksentijevich I, Pascual V, Wise CA (2010). "Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review". Current Genomics. 11 (7): 519–527. doi:10.2174/138920210793175921. PMC 3048314. PMID 21532836.
Claveau JS, Wetter DA, Kumar S (2022). "Cutaneous manifestations of monoclonal gammopathy". Blood Cancer Journal. 12 (4). doi:10.1038/s41408-022-00661-1. PMC 9001632. PMID 35411042. 58.

semanticscholar.org

api.semanticscholar.org

Partridge AC, Bai JW, Rosen CF, Walsh SR, Gulliver WP, Fleming P (August 2018). "Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials". The British Journal of Dermatology. 179 (2): 290–295. doi:10.1111/bjd.16485. PMID 29478243. S2CID 3504429.
Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G (September 2009). "Pyoderma gangrenosum: an updated review". Journal of the European Academy of Dermatology and Venereology. 23 (9): 1008–17. doi:10.1111/j.1468-3083.2009.03199.x. PMID 19470075. S2CID 29773727.
Shankar S, Sterling JC, Rytina E (November 2003). "Pustular pyoderma gangrenosum". Clinical and Experimental Dermatology. 28 (6): 600–3. doi:10.1046/j.1365-2230.2003.01418.x. PMID 14616824. S2CID 11350602.
Langan SM, Powell FC (August 2005). "Vegetative pyoderma gangrenosum: a report of two new cases and a review of the literature". International Journal of Dermatology. 44 (8): 623–9. doi:10.1111/j.1365-4632.2005.02591.x. PMID 16101860. S2CID 34574262.
Rashid RM (November 2008). "Seat belt pyoderma gangrenosum: minor pressure as a causative factor". Journal of the European Academy of Dermatology and Venereology. 22 (10): 1273–4. doi:10.1111/j.1468-3083.2008.02626.x. PMID 18837131. S2CID 27476857.
Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, et al. (April 2018). "Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts". JAMA Dermatology. 154 (4): 461–466. doi:10.1001/jamadermatol.2017.5980. hdl:2434/555642. PMID 29450466. S2CID 4774649.